The Patent Finder

Adherent Cells from Placenta and Use of Same in Disease Treatment

Pluri Biotech Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/IB2010/003219, filed Nov 29, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,175,262Adherent Cells from Placenta and Use of Same in Disease Treatment
In force
 · High confidence
Pluri Biotech Ltd.In force
High confidence
US 10,610,545Adherent Cells from Placenta and Use of Same in Disease Treatment
In force
 · High confidence
Pluri Biotech Ltd.In force
High confidence
Application 16/749,080Adherent Cells from Placenta and Use of Same in Disease Treatment
Abandoned
Abandoned Nov 14, 2023
Pluri Biotech Ltd.AbandonedAbandoned Nov 14, 2023
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Pluri Biotech Ltd..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited